New Research Poster 2 (open)
New Research Posters Session 2

Thursday, October 24, 2013: 10:00 AM-12:30 PM
 
2.1
Compulsive Behavior in Children and Adolescents with Autism Spectrum Disorders
Clara Espelt Hospital Clínic de Barcelona, Barcelona Spain
Mireia Rosa Hospital Clínic de Barcelona, Barcelona Spain
Ana Griselda Ortiz Hospital Clínic de Barcelona, Barcelona Spain
Luisa Lazaro, MD, PhD Hospital Clínic de Barcelona, Barcelona Spain
Olga Puig Cibersam, Madrid Spain
Rosa Calvo, MD, PhD Cibersam, Madrid Spain
 
2.2
Treatment Choices in Autism Spectrum Disorder
Danica C. Denton, DO Vanderbilt University Medical Center, Nashville, TN
Johanna K. Lake, PhD Centre for Addiction and Mental Health and the University of Toronto, Toronto, ON
Yona Lunsky, PhD Centre for Addiction and Mental Health and the University of Toronto, Toronto, ON
Evdokia Anagnostou, MD Holland Bloorview Kids Rehab, Toronto, ON
Jeremy Veenstra-VanderWeele, MD Vanderbilt University Medical Center, Nashville, TN
 
2.3
Parental and Perinatal Risk Factor for Autistic Spectrum Disorder
Cristina Domínguez Martín, MD Hospital Clínico Universitario de Valladolid, Valladolid Spain
Marta Brezmes Raposo, MD Hospital Clínico Universitario de Valladolid, Valladolid Spain
Carlos Ochoa Sangrador, MD Complejo Asistencial de Zamora, Zamora Spain
Mª Fe Muñoz Moreno, MD Hospital Clínico Universitario de Valladolid, Valladolid Spain
Marta Munozyerro, MD Hospital Clínico Universitario de Valladolid, Valladolid Spain
Carolina Gonzalez Gonzalez, MD Hospital Clínico Universitario de Valladolid, Valladolid Spain
 
2.4
MK801 Reverses Behavioral Defects Including Increased Locomotive Activity and Social Impairments in Prenatal Valproic Acid Exposure Model of Autism Spectrum Disorder
Geon Ho Bahn, MD Kyung Hee Univiversity School of Medicine, Seoul South Korea
Minha Hong, MD Kyung Hee University Hospital, Seoul South Korea
Yeon Jung Lee, MD Kyung Hee University Hospital, Seoul South Korea
Ki Chan Kim, PhD School of Medicine at Konkuk University, Seoul South Korea
Pitna Kim, MD School of Medicine at Konkuk University, Seoul South Korea
Chan Young Shin, PhD School of Medicine at Konkuk University, Seoul South Korea
 
2.5
Improving the Emotional Vocabulary of Children with Autism Spectrum Disorders Using the Serious Game Jestimule
Stéphanie Hun Centre Ressources Autisme, Nice France
Sylvie Serret, MD Centre Ressources Autisme, Nice France
Galina Iakimova, PhD Laboratoire d’Anthropologie et de Psychologie Cognitives et Sociales, Nice France
Florence Askenazy, MD Nice University Hospital, Nice France
 
2.6
Language Profile of Autism Spectrum Disorder Children: Language Differences According to Overlapping of Diagnosis of Mental Retardation or ADHD
Woo Young Im, MD Yosei University College of Medicine, Institute of Behavioral Science in Medicine, Seoul South Korea
Dong-Ho Song, MD, PhD Yosei University College of Medicine, Institute of Behavioral Science in Medicine, Seoul South Korea
Sun Young Kim, MD Yonsei University College of Medicine, Institute of Behavioral Science in Medicine, Seoul South Korea
Eun-Young Shin, MD Yosei University College of Medicine, Institute of Behavioral Science in Medicine, Seoul South Korea
Seungha Song, MA Severance Children’s Hospital and Yonsei University College of Medicine, Seoul South Korea
Kyeong In Seol, MD Severance Children’s Hospital and Yonsei University College of Medicine, Seoul South Korea
Keun-Ah Cheon, MD, PhD Yonsei University College of Medicine, Institute of Behavioral Science in Medicine, Seoul South Korea
 
2.7
Neural Response to Affective and Cognitive Theory of Mind in Children and Adolescents with Autism Spectrum Disorders
Eunjoo Kim, MD Yonsei University Graduate School, Seoul South Korea
Sunghyon Kyeong National Institute for Mathematical Sciences, Daejeon South Korea
Bumhee Park, PhD Yonsei University School of Medicine, Seoul South Korea
Ji-won Jhun, PhD Yonsei University School of Medicine, Seoul South Korea
Maeng-Keun Oh, MD Yonsei University School of Medicine, Seoul South Korea
Hae-Jeong Park, PhD Yonsei University School of Medicine, Seoul South Korea
Sun Young Kim, MD Yonsei University College of Medicine, Institute of Behavioral Science in Medicine, Seoul South Korea
Woo Young Lim, MD Yonsei University School of Medicine, Seoul South Korea
Eun-Young Shin, MD Yosei University College of Medicine, Institute of Behavioral Science in Medicine, Seoul South Korea
Dong-Ho Song, MD, PhD Yosei University College of Medicine, Institute of Behavioral Science in Medicine, Seoul South Korea
 
2.8
Having a Child with an Autism Spectrum Disorder: Impact and Resiliency
Maria Marti, MS Columbia University, New York, NY
Ellen Landau, LCSW Columbia University, New York, NY
Elaine S. Lavin, BA Columbia University, New York, NY
Jacob Hartman, MS Columbia University, New York, NY
Andrew J. Gerber, MD, PhD Columbia University, New York, NY
 
2.9
Mood Symptoms in Children and Adolescents with Autism Spectrum Disorders
Luigi Mazzone, MD I.R.C.C.S. Children's Hospital Bambino Gesù, Rome Italy
Valentina Postorino, PhD I.R.C.C.S. Children's Hospital Bambino Gesù, Rome Italy
Lavinia De Peppo Children's Hospital Bambino Gesù, Rome Italy
Laura Fatta, PsyD I.R.C.C.S. Children's Hospital Bambino Gesù, Rome Italy
Marco Armando, MD Children's Hospital Bambino Gesù, Rome Italy
Laura Reale, MD University of Catania, Catania Italy
GIulia Giovagnoli, PsyD I.R.C.C.S. Children's Hospital Bambino Gesù, Rome Italy
Stefano Vicari, MD I.R.C.C.S. Children's Hospital Bambino Gesù, Rome Italy
 
2.10
Assessment of Sleep Habits and Related Clinical Parameters of Sleep Problems in Children with Autism Spectrum Disorders
Tuba Mutluer, MD Istanbul University's Faculty of Medicine, Istanbul Turkey
Osman Abali, MD Istanbul University's Faculty of Medicine, Istanbul Turkey
 
2.11
Pharmacogenetic Study of Serotonin Transporter and 5HT2A Genotype in Autism
Fedra Najjar, MD University of Illinois, Chicago, IL
Jeffrey R. Bishop, PharmD University of Illinois at Chicago, Chicago, IL
Kwan Hur, PhD University of Chicago, Chicago, IL
Thomas Owley, MD Rush University Medical Center, Chicago, IL
Stephen Guter, MA University of Illinois, Chicago, IL
Robert Gibbons, PhD University of Chicago, Chicago, IL
Edwin H. Cook Jr., MD University of Illinois, Chicago, IL
 
2.12
Global Form Processing of Kanizsa Illusory Contours in Autism Spectrum Disorders
Kritika Nayar, BS New York University Child Study Center, New York, NY
Angela C. Voyles Center for Neural Science at New York University, New York, NY
F. Xavier Castellanos, MD The Phyllis Green and Randolph Cōwen Institute for Pediatric Neuroscience, New Yorl University Child Study Center, and New York University Langone Medical Center, New York, NY
Adriana Di Martino, MD The Phyllis Green and Randolph Cōwen Institute for Pediatric Neuroscience, New Yorl University Child Study Center, and New York University Langone Medical Center, New York, NY
Lynne Kiorpes, PhD Center for Neural Science at New York University, New York, NY
 
2.13
Rigid-Compulsive Behaviors Associated with Mixed Bowel Symptoms in Autism Spectrum Disorder
Brittany R. Peters, MD Vanderbilt University, Nashville, TN
Jeremy Veenstra-VanderWeele, MD Vanderbilt University, Nashville, TN
 
2.14
Extended Oxytocin Treatment of Children with Autistic Disorder
Linmarie Sikich, MD The University of North Carolina at Chapel Hill, Chapel Hill, NC
Terrence C. Bethea, MD ASPIRE Program, University of North Carolina at Chapel Hill, Burlington, NC
Cheryl Alderman, BS University of North Carolina at Chapel Hill, Chapel Hill, NC
Jacqueline Johnson, DrPH University of North Carolina at Chapel Hill, Chapel Hill, NC
 
2.15
Parental Stress in Families of Children with Autism and Other Developmental Disabilities
Maria Valicenti-McDermott, MD The Children's Evaluation and Rehabilitation Center at the Albert Einstein College of Medicine, Bronx, NY
Katherine Lawson, PhD The Children's Evaluation and Rehabilitation Center at the Albert Einstein College of Medicine, Bronx, NY
Kathryn Hottinger, BA The Children's Evaluation and Rehabilitation Center at the Albert Einstein College of Medicine, Bronx, NY
Rosa Seijo, MD The Children's Evaluation and Rehabilitation Center at the Albert Einstein College of Medicine, Bronx, NY
Merryl A. Schechtman, MD The Children's Evaluation and Rehabilitation Center at the Albert Einstein College of Medicine, Bronx, NY
Lisa Shulman, MD The Children's Evaluation and Rehabilitation Center at the Albert Einstein College of Medicine, Bronx, NY
Shlomo Shinnar, MD Montefiore Medical Center, the University Hospital for Albert Einstein College of Medicine, Bronx, NY
 
2.16
Are Emerging Treatments in Fragile X Syndrome Relevant to Autism Spectrum Disorder?
Jeremy Veenstra-VanderWeele, MD Vanderbilt University, Nashville, TN
Linmarie Sikich, MD The University of North Carolina at Chapel Hill, Chapel Hill, NC
Raun Melmed, MD Melmed Center, Scottsdale, AZ
Jana von Hehn, PhD Seaside Therapeutics, Inc., Cambridge, MA
Karen Walton-Brown U.S. Renal Care, Plano, TX
Maryann Cherubini Seaside Therapeutics, Inc., Cambridge, MA
Peter Zarevics Seaside Therapeutics, Inc., Cambridge, MA
Randall Carpenter Seaside Therapeutics, Inc., Cambridge, MA
Mark Bear, PhD Seaside Therapeutics, Inc., Cambridge, MA
Paul Wang, MD Seaside Therapeutics, Inc., Cambridge, MA
Edwin H. Cook Jr., MD University of Illinois, Chicago, IL
 
2.17
Interaction Between Cognitive Control and Emotional Responding in ADHD
James Blair, PhD National Institute of Mental Health, Bethesda, MD
Zachary T. Nolan, BA National Institutes of Health and National Institute of Mental Health, Bethesda, MD
Soonjo Hwang, MD National Institutes of Health and National Institute of Mental Health, Bethesda, MD
Stuart F. White, PhD National Institutes of Health and National Institute of Mental Health, Bethesda, MD
Stephen Sinclair, PhD National Institutes of Health and National Institute of Mental Health, Bethesda, MD
 
2.18
Latent Classes of ADHD and Oppositional Defiant Disorder: Associated Clinical and Psychosocial Features in a Large Referred Sample
Dillon T. Browne, MA University of Toronto, Toronto, ON
Alice Charach, MD, MSC University of Toronto, Toronto, ON
Annie Dupuis, PhD The Hospital for Sick Children, Toronto, ON
Jennifer Crosbie, PhD The Hospital for Sick Children, Toronto, ON
 
2.19
Activating and Tranquilizing Effects of First-Time Treatment with Aripiprazole, Olanzapine, Quetiapine, and Risperidone in Youth
Zainab Al-Dhaher, MD Zucker Hillside Hospital, Hofstra North Shore-LIJ School of Medicine, Glen Oaks, NY
Sandeep Kapoor, MD Zucker Hillside Hospital, Hofstra North Shore-LIJ School of Medicine, Glen Oaks, NY
Raja Chekuri, MD Zucker Hillside Hospital, Hofstra North Shore-LIJ School of Medicine, Glen Oaks, NY
Aseel Al-Jadiri, MD Zucker Hillside Hospital, Hofstra North Shore-LIJ School of Medicine, Glen Oaks, NY
Theodore Ake, BS Zucker Hillside Hospital, Hofstra North Shore-LIJ School of Medicine, Glen Oaks, NY
Lisa David, MD Zucker Hillside Hospital, Hofstra North Shore-LIJ School of Medicine, Glen Oaks, NY
Morgan Carella, BS Zucker Hillside Hospital, Glen Oaks, NY
Christoph U. Correll, MD Hofstra North Shore LIJ School of Medicine, Glen Oaks, NY
 
2.20
Citalopram for Pediatric Functional Abdominal Pain: A Randomized Controlled Trial
John V. Campo, MD The Ohio State University, Columbus, OH
Jeffrey Bridge, PhD The Research Institute at Nationwide Children's Hospital, Columbus, OH
Cynthia A. Fontanella, PhD The Ohio State University, Columbus, OH
Lipi Gupta, BA The Ohio State University, Columbus, OH
James Perel, PhD University of Pittsburgh, Pittsburgh, PA
Cari Dombrowski, MSW Nationwide Children's Hospital, Columbus, OH
Boris Birmaher, MD Western Psychiatric Institute & Clinic, Pittsburgh, PA
Amanda Lucas, MBA The Ohio State University, Columbus, OH
Carlo Di Lorenzo, MD Nationwide Children's Hospital, Columbus, OH
David A. Brent, MD Western Psychiatric Institute & Clinic, Pittsburgh, PA
 
2.21
Risk of Manic Switch Associated with Antidepressants in Pediatric Bipolar Depression
Hua Chen, MD, PhD University of Houston, College of Pharmacy, Houston, TX
Debajyoti Bhowmik, PhD University of Houston, College of Pharmacy, Houston, TX
Melissa Ochoa-Perez, MD Legacy Community Clinic, Houston, TX
Rajender R. Aparasu, PhD University of Houston, College of Pharmacy, Houston, TX
Suja S. Rajan, PhD University of Texas School of Public Health, Houston, TX
Jeff T. Sherer, PharmD University of Houston, College of Pharmacy, Houston, TX
 
2.22
Long-Term Use of Selective Serotonin Reuptake Inhibitors is Associated with Weight Gain in an Overweight Adolescent Population
Richard Cockerill, MA Mayo Clinic College of Medicine, Rochester, MN
Tyler Scott Oesterle, MD Mayo Clinic, Rochester, MN
Bridget Biggs, PhD Mayo Clinic College of Medicine, Rochester, MN
Paul E. Croarkin, DO Mayo Clinic, Rochester, MN
 
2.23
Ziprasidone Use Targeting Irritability in Youth with Autism Spectrum Disorder
Kelli C. Dominick, MD, PhD Cincinnati Children's Hospital Medical Center, Cincinnati, OH
Logan K. Wink, MD Cincinnati Children's Hospital Medical Center, Cincinnati, OH
Christopher J. McDougle, MD Massachusetts General Hospital, Lexington, MA
Craig A. Erickson, MD Cincinnati Children's Hospital Medical Center, Cincinnati, OH
 
2.24
Trend in Psychotropic Polypharmacy Among Youth Enrolled in Ohio Medicaid, 2002-2008
Cynthia A. Fontanella, PhD The Ohio State University, Columbus, OH
Lynn Warner, PhD University at Albany, State University of New York, Albany, NY
Gary Phillips, MAS The Ohio State University, Columbus, OH
Jeffrey Bridge, PhD The Research Institute at Nationwide Children's Hospital, Columbus, OH
John V. Campo, MD The Ohio State University, Columbus, OH
 
2.25
Antidepressant Exposure in Youth is Associated with Increased Risk for Fracture
Barbara Gracious, MD Nationwide Children's Hospital, Columbus, OH
Cynthia A. Fontanella, PhD The Ohio State University, Columbus, OH
Gary Phillips, MAS The Ohio State University, Columbus, OH
Jeffrey Bridge, PhD The Research Institute at Nationwide Children's Hospital, Columbus, OH
John V. Campo, MD The Ohio State University, Columbus, OH
 
2.26
Loxapine Neuromotor Side Effects in Autism Spectrum Disorders
Jessica A. Hellings, MD The Ohio State University Nisonger Center, Columbus, OH
Mandar Jadhav, BS Ross University School of Medicine, Roseau, Commonwealth of Dominica Dominica
Ann Genovese, MD University of Kansas Medical center, Kansas City, KS
Sneha Jadhav, MD University of Kansas Medical center, Kansas City, KS
Juan L. Brusés, MD University of Kansas Medical center, Kansas City, KS
 
2.27
Naturalistic Long Term Safety Results of Second-Generation Antipsychotics in Hospitalized Children and Adolescents
F Neslihan Inal-emiroglu, MD Dokuz Eylul University Medical School, Izmir Turkey
Sevay Alsen Necip Fazil Sehir Hastanesi, Kahramanmaraş Turkey
Burak Baykara, MD Dokuz Eylul University Medical School, Izmir Turkey
Aynur Akay, MD Dokuz Eylul University Medical School, Izmir Turkey
 
2.28
CYP2D6 and CYP2C9 Polymorphisms' Influence on Fluoxetine Plasmatic Concentration in Paediatric Patients
Luisa Lazaro, MD, PhD Hospital Clínic de Barcelona, Barcelona Spain
Mireia Pagerols, MS University of Barcelona, Barcelona Spain
Natalia Rodriguez, MS University of Barcelona, Barcelona Spain
Patricia Gasso, PharmD University of Barcelona, Barcelona Spain
Ana Blazquez, MS Fundació Clínic per a la Recerca Biomèdica, Barcelona Spain
M. Teresa Plana, MD Hospital Clínic de Barcelona, Barcelona Spain
Sergi Mas, PharmD University of Barcelona, Barcelona Spain
Amàlia Lafuente, PharmD University of Barcelona, Barcelona Spain
 
2.29
Biomarkers of Metabolic Risk in Children Treated with Antipsychotics: A Preliminary Study of Proximal Measures
Ginger E. Nicol, MD Washington University School of Medicine, St. Louis, MO
Michael Yingling, MS Washington University School of Medicine, St. Louis, MO
Julia Schweiger Washington University School of Medicine, St. Louis, MO
John W. Newcomer, MD Charles E. Schmidt College of Medicine, Florida Atlantic University, Boca Raton, FL
 
2.30
The Atomoxetine-Stimulant Side Effects Rating Scale: Factor Structure and Associated Clinical Characteristics for OROS Methylphenidate and Atomoxetine
Emily Olsen, MA University of Illinois, Chicago, IL
Anjuli Bodapati, MA University of Illinois, Chicago, IL
Jeffrey H. Newcorn, M.D. Icahn School of Medicine at Mount Sinai, New York, NY
Mark A. Stein, PhD University of Washington, Seattle, WA
 
2.31
The Short-Term Effects of Risperidone-Induced Hyperprolactinemia on Lipid Metabolism in Drug-Naïve Children and Adolescents
Eun Jin Park, MD Inje University Ilsan Paik Hospital, Goyang South Korea
Bongseog Kim, MD, PhD Sanggyepaik Hospital, Seoul South Korea
Young Min Park, MD Inje University Ilsan Paik Hospital, Goyang South Korea
 
2.32
What Leads to Antipsychotic Medication Treatment? Results from a Mandatory Statewide Survey
David C. Rettew, MD University of Vermont College of Medicine, Burlington, VT
Jeanne E. Greenblatt, MD, MPH University of Vermont, Charlotte, VT
Charles D. MacLean, MD University of Vermont, Burlington, VT
Jody L. Kamon, PhD University of Vermont, Burlington, VT
Diane Neal Catamaran, Worcester, MA
Nancy J. Hogue, BS, PharmD State of Vermont, Williston, VT
Patricia Berry, MPH University of Vermont, Burlington, VT
Richard C. Wasserman, MD, MPH University of Vermont, Burlington, VT
 
2.33
A Randomized, Placebo-Controlled Study of Duloxetine for the Treatment of Children (7-11 Years) and Adolescents (12-17 Years) with Generalized Anxiety Disorder
Jeffrey Robert Strawn, MD University of Cincinnati, Cincinnati, OH
Apurva Prakash, BA Eli Lilly and Company, Indianapolis, IN
Qi Zhang, PhD Eli Lilly and Company, Indianapolis, IN
Beth A. Pangallo, RN Eli Lilly and Company, Indianapolis, IN
Chad Stroud, PharmD Eli Lilly and Company, Indianapolis, IN
Na Cai, PhD Eli Lilly and Company, Indianapolis, IN
Robert L. Findling, MD, MBA The Johns Hopkins University/Kennedy Kreiger Institute, Baltimore, MD
 
2.34
The Impact of Extended-Release Stimulant Medication on the Growth Trajectories of Chidlren with ADHD
James Waxmonsky, MD Florida International University, Miami, FL
Hugh Humphery, MD Florida International University, Miami, FL
Kathy Monroy, MD Florida International University, Miami, FL
Rebecca Marshall Florida International University, Miami, FL
Adriana Campa, PhD Florida International University, Miami, FL
Lysett Babocsai, PhD Florida International University, Miami, FL
Tan Li, PhD Florida International University, Miami, FL
O Dale Williams, MPH Florida International University, Miami, FL
William Pelham, PhD Center for Children and Families, AHC1, Miami, FL
 
2.35
The Prediction of Pediatric Aggression on Inpatient Units
Drew H. Barzman, MD Cincinnati Children's Hospital Medical Center, Cincinnati, OH
Douglas Mossman, MD University of Cincinnati, Cincinnati, OH
Michael T. Sorter, MD Cincinnati Children's Hospital Medical Center, Cincinnati, OH
 
2.36
Laboratory-Based Impulsive Aggression and Family History of Suicidal Behavior in Adolescents with and without a History of Suicide Attempt
Kendra Heck, MPH Nationwide Children's Hospital, Columbus, OH
Jeffrey Bridge, PhD The Research Institute at Nationwide Children's Hospital, Columbus, OH
John V. Campo, MD The Ohio State University, Columbus, OH
David A. Brent, MD Western Psychiatric Institute & Clinic, Pittsburgh, PA
 
2.37
Nonverbal Intelligence in Young Children with Dysregulation: The Generation R Study
Maartje Basten, MS Erasmus Medical Center – Sophia Children's Hospital, Rotterdam Netherlands
Jan Van der Ende, MS Erasmus Medical Center – Sophia Children's Hospital, Rotterdam Netherlands
Henning Tiemeier, MD, PhD Erasmus Medical Center – Sophia Children's Hospital, Rotterdam Netherlands
Vincent W.V. Jaddoe, MD, PhD Erasmus Medical Center – Sophia Children's Hospital, Rotterdam Netherlands
James J. Hudziak, MD Vermont Center For Children, Youth, & Families, Burlington, VT
Frank C. Verhulst, MD, PhD Erasmus University Medical Center, Rotterdam Netherlands
Robert Althoff, MD, PhD University of Vermont, Burlington, VT
Tonya J. White, MD, PhD Erasmus Medical Center – Sophia Children's Hospital, Rotterdam Netherlands
 
2.38
Do Different ADHD-Related Etiological Risks Involve Specific Neuropsychological Pathways? An Analysis of Mediation Processes by Inhibitory Control and Delay Aversion
Katja Becker, MD Philipps University of Marburg, Marburg Germany
Tanja Mingebach Philipps University of Marburg, Marburg Germany
Alisa Roller Philipps University of Marburg, Marburg Germany
Silke Dalir Philipps University of Marburg, Marburg Germany
Ursula Pauli-Pott, PhD Philipps University of Marburg, Marburg Germany
 
2.39
What Do Child and Adolescent Psychiatric Disorders Predict? Prospective-Longitudinal Associations with Adult Psychopathology
Katja Beesdo-Baum, PhD Technische Universität Dresden, Dresden Germany
Daniel Pine, MD National Institute of Mental Health, Bethesda, MD
Michael Hoefler, PhD Technische Universität Dresden, Dresden Germany
Roselind Lieb, PhD University of Basel, Basel Switzerland
Hans-Ulrich Wittchen, PhD Technische Universität Dresden, Dresden Germany
 
2.40
Repetitive Negative Thinking as a Transdiagnostic Vulnerability Factor for Emotional Problems
Patricia Bijttebier, PhD Katholieke Universiteit Leuven, Leuven Belgium
Filip Raes, PhD University of Leuven, Leuven Belgium
Michael W. Vasey, PhD The Ohio State University, Columbus, OH
Margot Bastin, MD Katholieke Universiteit Leuven, Leuven Belgium
Thomas Ehring, PhD Westfälische Wilhelms-Universität Münster, Münster Germany
 
2.42
Children at High-Risk for Bipolar Disorder: Correlating Cortical Thinning to Peripheral Markers of Oxidative Stress
Lindsay Hanford, BS McMaster University, Hamilton, ON
Luciano Minuzzi, MD, PhD McMaster University, Hamilton, ON
Lauren Cudney, BS McMaster University, Hamilton, ON
Manpreet Sehmbi, BS McMaster University, Hamilton, ON
Guilherme Behr, PhD McMaster University, Hamilton, ON
Benicio Frey, MD, PhD McMaster University, Hamilton, ON
Geoffrey Hall, PhD McMaster University, Hamilton, ON
Roberto Sassi, MD, PhD McMaster University, Hamilton, ON
 
2.43
Physical Activity Intervention for Young Children At-Risk for ADHD
Betsy Hoza, PhD University of Vermont, Burlington, VT
Alan L. Smith, PhD Michigan State University, East Lansing, MI
Erin K. Shoulberg, PhD University of Vermont, Burlington, VT
Kate S. Linnea, BA University of Vermont, Burlington, VT
Travis E. Dorsch, PhD Purdue University, West Lafayette, IN
Jordan A. Blazo, MS Michigan State University, East Lansing, MI
Caitlin Alerding, MS Purdue University, West Lafayette, IN
George P. McCabe, PhD Purdue University, West Lafayette, IN
 
2.45
Predicting Internalizing Disorder Symptoms from Symptom Dimensions of Oppositional Defiant Disorder in School-Aged Children
Jadzia Anna Jagiellowicz, PhD University of Sherbrooke, Longueuil Canada
Jean Toupin, PhD University of Sherbrooke, Longueuil Canada
Michele Déry, PhD University of Sherbrooke, Sherbrooke, QC
Mélanie Lapalme, PhD University of Sherbrooke, Sherbrooke, QC
 
2.46
Evolution of ADHD Symptoms from Childhood Through Adolescence with or without Comorbid Disruptive Behavior Disorders: Moderating Effect of Gender
Mélanie Lapalme, PhD University of Sherbrooke, Sherbrooke, QC
Maxime Dube, BA University of Sherbrooke, Sherbrooke, QC
Michele Déry, PhD University of Sherbrooke, Sherbrooke, QC
 
2.48
Reducing Autism Prevalence: A Surprising but Possible Public Policy Opportunity
Julia G. Leventhal, BA University of North Carolina Charlotte, Charlotte, NC
Young-Shin Kim, MD Nathan S. Kline Institute for Psychiatric Research, Orangeburg, NY
Yun-Joo Koh, PhD Korea Institute for Children's Social Development, Seoul South Korea
Matthew State, MD, PhD University of California, San Francisco, San Francisco, CA
Ji-Hyun Kim, BA Korea Institute for Children's Social Development, Seoul South Korea
Bennett L. Leventhal, MD Yonsei University, Seoul South Korea
 
2.49
Sleep Characteristics in Preschool Children with ADHD: Actigraphic and Parental Reports
Maria Grazia Melegari, MD Tutela Salute Mentale dell'Età Evolutiva, Rome Italy
Alessandra Devoto, MS Sapienza University of Rome, Rome Italy
Elena Vittori, MD Centro Ricerche e Cura Balbuzie, Rome Italy
Fabio Lucidi, PhD Sapienza University of Rome, Rome Italy
Luca Mallia, PhD Sapienza University of Rome, Rome Italy
Oliviero Bruni, MD Sapienza University of Rome, Rome Italy
 
2.51
Molecular Mimicry in a Mouse Model of Autism
Demian F. Obregon, MD Morsani College of Medicine at the University of South Florida, Tampa, FL
Yuyan Zhu, DPhil Morsani College of Medicine at the University of South Florida, Tampa, FL
Antoinette Bailey, MS Morsani College of Medicine at the University of South Florida, Tampa, FL
Samantha M. Portis, MS Morsani College of Medicine at the University of South Florida, Tampa, FL
Huayan Hou, MS Morsani College of Medicine at the University of South Florida, Tampa, FL
Jin Zeng, BA Morsani College of Medicine at the University of South Florida, Tampa, FL
Saundra Stock, MD Morsani College of Medicine at the University of South Florida, Tampa, FL
Tanya K. Murphy, MD University of South Florida, St. Petersburg, FL
Michael Bengtson, MD University of South Florida, Tampa, FL
Jun Tan, MD, PhD Morsani College of Medicine at the University of South Florida, Tampa, FL
 
2.52
The Association Between Physical Activity, Exercise Type, and Withdrawn/Depressed Symptoms in a Clinical Sample of Children and Adolescents
Meghan Schreck, BA University of Vermont, Burlington, VT
Robert Althoff, MD, PhD University of Vermont, Burlington, VT
Meike Bartels, PhD Vrije Universiteit, Amsterdam Netherlands
Eco de Geus, PhD Vrije Universiteit, Amsterdam Netherlands
Christine Giummo, MS University of Vermont, Burlington, VT
James J. Hudziak, MD Vermont Center For Children, Youth, & Families, Burlington, VT
 
2.54
Emotional Face Identification in Adolescent Suicide Attempters Compared to Adolescents Engaged in Non-Suicidal Self-Injury
Karen E. Seymour, PhD Bradley Hospital PediMIND Program, Brown University, East Providence, RI
Grace K. Cushman, BS Bradley Hospital PediMIND Program, Brown University, East Providence, RI
Thania Galvan, BA Bradley Hospital PediMIND Program, Brown University, East Providence, RI
Megan E. Puzia, BA Bradley Hospital PediMIND Program, Brown University, East Providence, RI
Kerri L. Kim, PhD Bradley Hospital PediMIND Program, Brown University, East Providence, RI
Anthony Spirito, ABPP, PhD Bradley Hospital and Brown University, East Providence, RI
Daniel P. Dickstein, MD Bradley Hospital PediMIND Program, Brown University, East Providence, RI
 
2.55
Updated Meta-Analysis of the Clinical Characteristics of Mania in Children and Adolescents
Anna R. Van Meter, PhD Yeshiva University, Bronx, NY
Coty Burke University of North Carolina, Chapel Hill, NC
Robert A. Kowatch, MD, PhD Nationwide Children's Hospital, Columbus, OH
Robert L. Findling, MD, MBA The Johns Hopkins University/Kennedy Kreiger Institute, Baltimore, MD
Eric Youngstrom, PhD University of North Carolina at Chapel Hill, Chapel Hill, NC
 
2.56
Sleep Spindles and Auditory Gating: The Relationship Between Two Measures of Cerebral Inhibition
Peng F. Wei, BA University of Colorado School of Medicine, Aurora, CO
Sharon K. Hunter, PhD University of Colorado School of Medicine, Aurora, CO
Randal G. Ross, MD University of Colorado Denver, Aurora, CO
 
2.57
Top Down Attention Control and Emotional Responding in Conduct Disorder
Soonjo Hwang, MD National Institutes of Health and National Institute of Mental Health, Bethesda, MD
Stuart F. White, PhD National Institutes of Health and National Institute of Mental Health, Bethesda, MD
Zachary T. Nolan, BA National Institutes of Health and National Institute of Mental Health, Bethesda, MD
Stephen Sinclair, PhD National Institutes of Health and National Institute of Mental Health, Bethesda, MD
James Blair, PhD National Institute of Mental Health, Bethesda, MD

See more of: New Research Poster
Copyright ©2013 - American Academy of Child Adolescent Psychiatry. All Rights Reserved.